US Broker Ratings

Ascentage Pharma Group International (AAPG) Investor Outlook: Navigating Growth in Biotech with a 7.62% Upside Potential

Ascentage Pharma Group International (AAPG), a pioneering clinical-stage biotechnology firm based in Suzhou, China, commands attention within the healthcare sector. With a market capitalization of $3.28..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring the 12% Potential Upside for Investors

Veracyte, Inc. (NASDAQ: VCYT), a leading player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors. With its current market..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring Growth Potential with a 5.06% Upside

Investors looking for opportunities in the healthcare sector may want to take a closer look at Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN). This Rockville, Maryland-based biopharmaceutical company..

Kiniksa Pharmaceuticals (KNSA): Investor Outlook on a 29% Upside Potential in the Biopharma Space

Kiniksa Pharmaceuticals, Ltd. (KNSA) is making waves in the healthcare sector, specifically within the niche of drug manufacturing that focuses on specialty and generic products. With..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a 20% Upside Potential

Twist Bioscience Corporation (NASDAQ: TWST), a leader in the diagnostics and research sector, is capturing investor attention with its innovative approach to synthetic DNA manufacturing. Headquartered..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: A Potential 63% Upside in the Biotech Sector

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology industry with its promising growth potential and a significant upside that could catch the eye of..

PROCEPT BioRobotics (PRCT) Stock Analysis: A Healthcare Innovator with 80.59% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) stands out in the healthcare sector as a promising player, particularly within the medical devices industry. With a focus on innovative..

Belite Bio, Inc (BLTE) Stock Analysis: A Closer Look at the Biotech Firm’s Growth Potential Amidst Promising Clinical Trials

Belite Bio, Inc (NASDAQ: BLTE) is capturing investor attention with its current market performance and promising pipeline of innovative therapeutic solutions. As a clinical-stage biopharmaceutical company,..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 25.95% Potential Upside in the Healthcare Sector

DENTSPLY SIRONA Inc. (XRAY), a prominent player in the healthcare sector, stands out in the medical instruments and supplies industry with its extensive portfolio of dental..

Concentra Group Holdings (CON): Healthcare Stock with 40% Upside Potential

For investors looking to capitalize on growth within the healthcare sector, Concentra Group Holdings Parent (CON) offers an intriguing opportunity. Positioned at the intersection of medical..

MoonLake Immunotherapeutics (MLTX): Potential Upside with Innovative Biotech Solutions

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss biotechnology firm, is carving a niche in the healthcare sector by developing therapies targeting inflammatory skin and joint diseases. The..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 49% Potential Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the healthcare sector, stands at a pivotal moment for investors seeking opportunities in the medical instruments and..

Denali Therapeutics Inc. (DNLI) Investor Outlook: Uncovering 83% Upside Potential Amid Neurodegenerative Treatment Innovation

Denali Therapeutics Inc. (DNLI) stands out in the biotechnology industry with a promising pipeline aimed at tackling some of the most challenging neurodegenerative and lysosomal storage..

Acadia Healthcare (ACHC) Stock Analysis: A 22% Upside in Behavioral Healthcare Sector

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent player in the behavioral healthcare sector, presents a compelling opportunity for investors, particularly with a potential upside of..

Warby Parker Inc. (WRBY) Stock Analysis: Evaluating a 22% Potential Upside with Solid Buy Ratings

Investors looking for an intriguing play in the healthcare sector might find Warby Parker Inc. (NYSE: WRBY) an appealing option. With a market capitalization of $2.65..

GeneDx Holdings Corp. (WGS) Stock Analysis: Navigating Growth with a 45.6% Revenue Surge

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the diagnostics and research industry, is capturing investor attention with its impressive 45.6% revenue growth in the..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 49% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector may find HUTCHMED (China) Limited (HCM) an intriguing opportunity, particularly given the stock’s potential upside of nearly 49.29%. Headquartered in Hong..

Organon & Co. (OGN) Stock Analysis: Exploring a 40.69% Potential Upside Amidst Healthcare Sector Challenges

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, operates within the general drug manufacturing industry, offering a diverse portfolio of prescription therapies..

Merus N.V. (MRUS) Stock Analysis: A Promising Biotech with 2.71% Upside Potential

Merus N.V. (NASDAQ: MRUS) has recently captured investor attention with its notable presence in the biotechnology sector. Headquartered in Utrecht, Netherlands, Merus is a clinical-stage immuno-oncology..

Metsera, Inc. (MTSR) Stock Analysis: A Biotech Player with 4.82% Potential Upside

Metsera, Inc. (NASDAQ: MTSR) is carving a niche in the competitive biotechnology sector with its innovative approach to tackling obesity and related metabolic disorders. Despite being..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds